BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6231139)

  • 21. The biochemical basis for mucopolysaccharidoses and mucolipidoses.
    Neufeld EF
    Prog Med Genet; 1974; 10():81-101. PubMed ID: 4283415
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Phenotypic variation in alpha-L-iduronidase deficiency.
    Leisti J; Rimoin DL; Kaback MM; Hollister DW; DEn Tandt W; Neufeld E; Matalon R; Philippart M
    Lancet; 1975 Jun; 1(7920):1344. PubMed ID: 49545
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation and characterization of peptidoglycans in urine from patients with mucopolysaccharidoses.
    Tanaka Y; Takazono I
    Int J Biochem; 1984; 16(5):435-46. PubMed ID: 6233194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ca2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate.
    Hamazaki H
    J Biol Chem; 1987 Feb; 262(4):1456-60. PubMed ID: 2948956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
    Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.
    Anson DS; Bielicki J; Hopwood JJ
    Hum Gene Ther; 1992 Aug; 3(4):371-9. PubMed ID: 1525210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of glycosaminoglycans by human embryonic lung fibroblasts. Different distribution of heparan sulphate, chondroitin sulphate and dermatan sulphate in various fractions of cell culture.
    Sjöberg I; Fransson LA
    Biochem J; 1977 Nov; 167(2):383-92. PubMed ID: 202253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosaminoglycan-degrading enzymes in the varicose vein wall.
    Kowalewski R; Sobolewski K; Malkowski A; Gacko M; Rutkowska I
    Int Angiol; 2008 Dec; 27(6):529-35. PubMed ID: 19078917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of heparan sulfate and dermatan sulfate.
    Conrad HE
    Ann N Y Acad Sci; 1989; 556():18-28. PubMed ID: 2525357
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis of the mucopolysaccharidoses using cultured skin fibroblasts and amniotic fluid cells.
    Butterworth J
    J Inherit Metab Dis; 1978; 1(1):25-8. PubMed ID: 117232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate.
    Freeman C; Hopwood JJ
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):899-908. PubMed ID: 1554373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separation of dermatan sulfate from heparan sulfate in mucopolysaccharidosis urine by chromatography on Sephadex G-75.
    Herd JK; Forrest T; Tschida J
    Clin Chim Acta; 1976 Apr; 68(1):1-9. PubMed ID: 131009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteoglycans from cultures of fibroblast from the human uterine cervix.
    Uldbjerg N; Malmström A; Ekman G; Ulmsten U
    Gynecol Obstet Invest; 1985; 19(3):146-54. PubMed ID: 3160640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical definition of the mucopolysaccharidoses.
    Constantopoulos G; Dekaban AS
    Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I.
    Shull RM; Munger RJ; Spellacy E; Hall CW; Constantopoulos G; Neufeld EF
    Am J Pathol; 1982 Nov; 109(2):244-8. PubMed ID: 6215865
    [No Abstract]   [Full Text] [Related]  

  • 36. Post- and pre-natal assessment of alpha-L-iduronidase deficiency with a radiolabelled natural substrate.
    Hopwood JJ; Muller V; Pollard AC
    Clin Sci (Lond); 1979 Jan; 56(6):591-9. PubMed ID: 113163
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Biochem Biophys Res Commun; 1976 Mar; 69(1):158-66. PubMed ID: 130905
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.
    Clements PR; Brooks DA; McCourt PA; Hopwood JJ
    Biochem J; 1989 Apr; 259(1):199-208. PubMed ID: 2470345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of cultured human fibroblasts in diabetes mellitus: changes in heparan sulfate.
    Silbert CK; Kleinman HK
    Diabetes; 1979 Jan; 28(1):61-4. PubMed ID: 153251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variant of iduronidase deficient mucopolysaccharidoses: further evidence for genetic heterogeneity.
    Danes BS
    J Med Genet; 1977 Oct; 14(5):346-51. PubMed ID: 412969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.